Bipartisan group pushes CMS to expand coverage for Alzheimer’s treatments
By
Kimberly Bonvissuto
Feb 21, 2023
Access to federally approved monoclonal antibody and other disease-modifying therapies for Alzheimer’s disease will be “extremely limited” unless the Centers for Medicare & Medicaid Services reconsiders...
Failing to cover Alzheimer’s therapies a costly proposition: researchers
By
Kimberly Bonvissuto
Jun 16, 2023
Not managing Alzheimer’s disease and related dementias is a costly proposition not just to families, but also to society, according to two recent studies.
More news for Monday, Feb. 5
By
Kimberly Bonvissuto
Feb 05, 2024
Takeaways from NIC MAP’s fourth-quarter fundamentals release … Use of Medicaid wraparound services by dually eligible individuals varies by service, state … StartUp Health launches global Alzheimer’s...
More news for Friday, Oct. 7
By
Kimberly Bonvissuto
Oct 07, 2022
WHO sets 2030 deadline to find Alzheimer’s cure … Report informs how to improve housing for older adults while addressing inequities … Most Americans want strong, sustainable Medicaid program …...
More news for Tuesday, Aug. 31
Aug 31, 2021
Groups request extension for vaccine mandate in Maine … Senior housing providers can take action to protect older adults from the end of eviction moratorium … Multiple defendants indicted in ‘grandparent...
2023 proved to be a ‘landmark’ year in progress toward treatment of Alzheimer’s disease
By
Kimberly Bonvissuto
Dec 15, 2023
The 2023 update to the nation’s roadmap of strategies and actions to address Alzheimer’s disease was released Wednesday, highlighting “landmark” progress made over the past year in understanding...
Lawmakers chide HHS for ‘eroding the pathway’ to Alzheimer’s treatments
By
Kimberly Bonvissuto
Mar 24, 2023
With personal stories of the effects that Alzheimer’s disease has had on them, lawmakers in a Senate Finance Committee hearing on Wednesday called for the federal government to speed up access to treatments....
Bipartisan group of 23 state AGs joins call for unrestricted coverage of Alzheimer’s treatments
By
Kimberly Bonvissuto
May 03, 2023
A bipartisan group of attorneys general from 23 states have joined a growing chorus calling on Medicare to reverse a previous decision and provide unrestricted coverage of Food and Drug Administration-approved...
Dementia to cost nation $321 billion this year, Alzheimer’s Association says
By
Kimberly Bonvissuto
Mar 16, 2022
This year, Alzheimer’s and other dementias will cost the nation $321 billion, increasing to $1 trillion by 2050, according to a report released Tuesday by the Alzheimer’s Association.
NIH requests additional $321M for Alzheimer’s, dementia research
By
Kimberly Bonvissuto
Aug 02, 2022
The National Institutes of Health has requested an additional $321 million in fiscal year 2024 for research into Alzheimer’s and other dementias.